Clinical Trial Update: Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of CD 2027 Spray in Adults With Plaque-type Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 pharmacokinetic and pharmacodynamic study of CD 2027 spray in adults with plaque-type psoriasis completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque-type Psoriasis

Drugs mentioned

• CD 2027 spray (CD 2027 spray)

Snippet

Sponsor: Galderma R&D | Conditions: Plaque-type Psoriasis | Phase 2 | Status: COMPLETED